Skip to main content

TGA approves provisional determination for Biocelect Pty Ltd for COVID-19 vaccine, Nuvaxovid

TGA, part of the Department of Health, has granted a second provisional determination to Biocelect Pty Ltd (on behalf of Novavax Inc.) in relation to its COVID-19 vaccine, Nuvaxovid.

Related content

Help us improve the Therapeutic Goods Administration site